Abstract Body

Depression affects 25–30% of people with HIV (PWH) in South Africa (RSA) and is associated with antiretroviral therapy (ART) nonadherence and increased mortality. We evaluated the cost-effectiveness of an 8-session cognitive behavioral therapy (CBT) intervention that improved clinical outcomes in a recent randomized controlled trial for PWH diagnosed with depression and first-line virologic failure in RSA.

Using the Cost-Effectiveness of Preventing AIDS Complications microsimulation model, we simulated two treatment strategies: 1) Enhanced treatment as usual (ETAU), a nurse-led evaluation of depression with referral to the participant’s HIV provider, and 2) ETAU plus 8 weekly CBT sessions focused on ART adherence and depression (CBT-AD). Cohort characteristics included mean initial age (39y; standard deviation [SD]: 9y) and CD4 count (214/?L; SD: 182/?L). We modeled the monthly probability of HIV mortality (0.002–0.095), CD4-stratified quality-of-life estimates for untreated depression (0.64–0.68) and CBT-treated depression (0.80–0.86), and costs of ART ($6–22/month) and CBT ($29/session). We calibrated to viral suppression at one year in the trial: 20% (ETAU) versus 32% (CBT-AD). Beyond one year, we projected 5y and 10y viral suppression, life expectancy, lifetime costs, and incremental cost-effectiveness ratios (ICERs: $/QALY [quality-adjusted life-year], discounted 3%/year). Based on a recent RSA economic threshold study, we considered a strategy cost-effective if its ICER was ?$2,545/QALY [0.5x annual [i]per capita[/i] GDP in RSA]. We conducted sensitivity analyses to determine how input parameter variation affected model results.

Model-projected 5y/10y viral suppression was 18.9%/8.7% (ETAU) compared with 21.1%/9.7% (CBT-AD) (Table). Compared with ETAU, CBT-AD would increase discounted life expectancy from 4.12 to 4.68 QALYs and discounted lifetime costs from $6,210/person to $6,610/person, resulting in an ICER of $730/QALY. The only scenarios where CBT-AD was not cost-effective (ICER >$2,545/QALY) occurred when CBT-AD improved one-year viral suppression by <2% and also cost ?$75/session.

An 8-session CBT intervention for PWH with depression and virologic failure in RSA is projected to improve life expectancy and be cost-effective. CBT-style interventions should be integrated into HIV care in South Africa and other low-/middle-income settings with high burdens of HIV and depression.